Kenvue (KVUE) Stock Analysis & Winston Score

Kenvue is a consumer health company that makes everyday products people buy at pharmacies and grocery stores. Its brands include Tylenol, Neutrogena, Listerine, Band-Aid, and Aveeno — names most households already recognize. The company was spun off from Johnson & Johnson in 2023, making it one of the largest standalone consumer health companies in the world. Kenvue earns money by selling its products directly to retailers, pharmacies, and e-commerce platforms, which then sell to everyday consumers. It operates globally, with strong sales across North America, Europe, and Asia-Pacific, and generates over $15 billion in annual revenue. Its main competitive advantage is brand recognition — consumers tend to reach for familiar names like Tylenol or Band-Aid out of habit. The key risk is that retailers are pushing their own cheaper store-brand alternatives, which could pressure Kenvue's pricing power and market share over time.